Akoya Biosciences, Inc. announced the appointment of Dr. Ehab A. El-Gabry as the company's Chief Medical Officer (CMO). In this newly created position, Dr. El-Gabry will lead Akoya's strategy in advancing the use of its spatial phenotyping solutions in the clinical setting. At Akoya, Dr. El-Gabry will be a key member of the executive leadership team, responsible for the direction and execution of the company's translational research and clinical strategy.

He will be focused on the evaluation and commercial development of the company's platforms for future clinical use, including regulatory submissions, cross-sector collaborations with academia and industry, and will ensure that the company's portfolio of cutting-edge products and services meets the needs of patients, providers, payors, and regulatory agencies. He served as Roche Pharma Services Medical Director and provided medical oversight for Roche Digital Solutions, Roche's portfolio of digital pathology platforms.